• Ayodeji Otufowora, Kathleen L Egan, Piyush V Chaudhari, Aderonke A Okusanya, Afeez O Ogidan, and Linda B Cottler.
• From the Department of Pediatrics, Columbia University Medical Center, Columbia University, New York, NY (AO), Department of Implementation Science, Division of Public Health Sciences, Wake Forest University School of Medicine, NC (KLE), Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL (PVC), Department of Pharmacy, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA (AAO), Department of Medicine & Surgery, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Sagamu campus, Ogun State, Nigeria (AOO), Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL(LBC). ao2895@cumc.columbia.edu.
• J Am Board Fam Med. 2024 Mar 11; 37 (1): 112117112-117.

ImportanceA substantial number of opioid analgesics dispensed into communities will go unused and be susceptible to diversion for misuse. Convenient, efficient, and environmentally safe mechanisms for disposal are needed to prevent the diversion of unused opioid analgesics.ObjectiveThis initiative piloted the feasibility of distributing drug deactivation pouches in a community setting and examined community members' acceptance, intention to use drug deactivation pouches, and their current disposal practices of unused opioid analgesics. Although many studies have examined the benefits of deactivation pouches in preventing drug overdose, few have explored community members' perspectives, the feasibility, and the acceptability of these pouches in disposing of unused medications.MethodsIn the fall of 2017, we piloted the distribution of drug deactivation pouches to assess the overall interest in the pouches at a 3-day community event and continued the second wave of this pilot in the community from the summer of 2018 to the spring of 2019.Our main outcomes and measures included the acceptance of the drug deactivation pouches and the intention to use the pouches. "Acceptance" was defined as study participants physically taking the kit and "Intention" was how participants intended to use the pouch.ResultsA total of 170 community members were approached at a community event about the drug deactivation pouches and 116 accepted at least 1 pouch (68.2% acceptance rate). In the second wave, 124 community members were approached by Community Health Workers; 100% accepted the pouch. Overall, the acceptance rate was 81.6%. People mentioned significant interest in using the pouches. Furthermore, surveys that assessed community members' intention to use the deactivation pouches showed that 48% intended to use the pouch.Conclusions And RelevanceThe distribution of drug deactivation pouches is feasible in a community setting and although community members expressed interest in using drug deactivation pouches to dispose of unused opioid analgesics and other drugs, the majority still disposed of their unused medications through other avenues. This, underscore the need to raise community members' awareness about the importance, benefits, and viability of these pouches as a tool for the primary prevention of opioid overdose because of their ease of use, safety, environmental considerations, and cost-effectiveness.© Copyright by the American Board of Family Medicine.

16 keywords...

hide…